Skip to content

Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.

Impact of Ergospirometric Oxygen Uptake Under Exercise as Diagnostic Marker of Cardiac Ischemia in Patients With Stable Angina Compared to Non Invasive and Invasive (FFR) Measurement of Ischemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04450459
Acronym
ADVANCE
Enrollment
121
Registered
2020-06-29
Start date
2019-01-02
Completion date
2025-08-25
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable Angina

Keywords

FFR Measurement; exercise testing, ergospirometer

Brief summary

In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection. Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.

Interventions

DIAGNOSTIC_TESTergospirometer test

ergospirometric test will be done before cardiac catheterisation and invasive measurement of FFR

Sponsors

Jena University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* stable Angina (CCS \>1-3) with suspected CAD or * dyspnoea at exertion NYHA \>2 or * signs of ischemia within SPECT or exercise electrocardiography * willingness to participate in the trial

Exclusion criteria

* Unstable angina or myocardial infarction within the last 2 weeks * inability to perform bicycle exercise test * significant valvular disease * HOCM * av- block \>I degree * asthma bronchiales

Design outcomes

Primary

MeasureTime frameDescription
double slope sign of ΔV̇O2/ΔWR-Increasebaselinedouble slope sign of ΔV̇O2/ΔWR by ergospirometer test

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORSven Möbius-Winkler, MD

Universityhospital Jena

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026